Literature DB >> 9655269

The changing face of mesenteric infarction.

T S Newman1, T H Magnuson, S A Ahrendt, M A Smith-Meek, J S Bender.   

Abstract

Intestinal infarction remains a devastating event despite improvements in clinical recognition as well as diagnostic and therapeutic modalities. Recent changes in the etiology of this disease have not been examined. A retrospective review of 121 consecutive patients over a 6-year period was undertaken. Twenty-three patients died without operation, and mortality in the remaining 98 patients was 50 per cent. The only significant predictor of mortality was an elevated serum lactate at the time of diagnosis. Thirty-one patients (26%) developed infarction while hospitalized for another disease process; excluding patients with obstruction as the etiology of infarction caused this number to rise to 39 per cent. Nonocclusive mesenteric infarction was the most common disease process. The increased incidence of nonocclusive mesenteric infarction is likely due to the development of intestinal ischemia in already systemically ill patients. Nearly half of all cases of intestinal infarction due to nonobstructive causes develop in already hospitalized patients. The development of unexplained acidosis in a postoperative or critically ill patient should prompt a search for a reversible cause of mesenteric ischemia. Intestinal infarction may represent another example of the multisystem organ failure syndrome.

Entities:  

Mesh:

Year:  1998        PMID: 9655269

Source DB:  PubMed          Journal:  Am Surg        ISSN: 0003-1348            Impact factor:   0.688


  9 in total

Review 1.  Multidetector CT imaging in mesenteric ischemia--pearls and pitfalls.

Authors:  Ashish Wasnik; Ravi K Kaza; Mahmoud M Al-Hawary; Peter S Liu; Joel F Platt
Journal:  Emerg Radiol       Date:  2010-12-04

Review 2.  Etiology and therapeutic approach to elevated lactate levels.

Authors:  Lars W Andersen; Julie Mackenhauer; Jonathan C Roberts; Katherine M Berg; Michael N Cocchi; Michael W Donnino
Journal:  Mayo Clin Proc       Date:  2013-10       Impact factor: 7.616

Review 3.  Current status on plasma biomarkers for acute mesenteric ischemia.

Authors:  Stefan Acosta; Torbjörn Nilsson
Journal:  J Thromb Thrombolysis       Date:  2012-05       Impact factor: 2.300

4.  Alcohol dehydrogenase: a potential new marker for diagnosis of intestinal ischemia using rat as a model.

Authors:  Upendra R Gumaste; Mukund M Joshi; Devendra T Mourya; Pradip V Barde; Ghanshyam K Shrivastav; Vikram S Ghole
Journal:  World J Gastroenterol       Date:  2005-02-14       Impact factor: 5.742

5.  Intraluminal intestinal administration of oxygenated perfluorocarbon improves acid-base and cardiopulmonary parameters after acute mesenteric ischemia. An experimental study in rabbits.

Authors:  Dimitrios K Papadimitriou; Georgios A Pitoulias; Basilios T Papaziogas; Maria D Tachtsi; Eustratios D Kalaitzis
Journal:  Surg Today       Date:  2007-03-26       Impact factor: 2.549

Review 6.  [Intestinal malperfusion in critical care patients].

Authors:  G Knichwitz; C Kruse; H van Aken
Journal:  Anaesthesist       Date:  2005-01       Impact factor: 1.041

7.  Does the concomitant intra-arterial injection of asialoerythropoietin and edaravone mitigate ischaemic mucosal damage after acute superior mesenteric artery thromboembolism in a rabbit autologous fibrin clot model?

Authors:  A Sonoda; N Nitta; A Seko; S Ohta; S Takemura; T Sugimoto; T Uzu; Y Yokomaku; M Takahashi; A Kashiwagi; K Murata
Journal:  Br J Radiol       Date:  2009-06-22       Impact factor: 3.039

8.  Isolated Large Cell Calcifying Sertoli Cell Tumor in a Young Boy, not Associated with Peutz-Jeghers Syndrome or Carney Complex.

Authors:  Jin-Ping Lai; Chyi-Chia Lee; Melissa Crocker; Mufaddal Najmuddin; Eileen Lange; Maria Merino; Constantine A Stratakis
Journal:  Ann Clin Lab Res       Date:  2015

9.  Can the Preoperative Serum Lactate Level Predict the Extent of Bowel Ischemia in Patients Presenting to the Emergency Department with Acute Mesenteric Ischemia?

Authors:  Peter C Ambe; Kai Kang; Marios Papadakis; Hubert Zirngibl
Journal:  Biomed Res Int       Date:  2017-02-05       Impact factor: 3.411

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.